Inventor · disambiguated record
George Hardy
Also filed as: HARDY GEORGE · HARDY GEORGE W
11 granted patents·2 pending applications·41 citations·filing 1982–2017
87Inventor score
Top patents by PatentIndex Score
13 records- 0185US8741909B2PI3 kinase inhibitorsKING-UNDERWOOD JOHN·Filed 2010·Granted Jun 3, 2014·7 cites·25 claims
- 0278US9321773B2CompoundsRESPIVERT LTD·Filed 2014·Granted Apr 26, 2016·2 cites·1 claims
- 0374US9834560B2CompoundsRESPIVERT LTD·Filed 2016·Granted Dec 5, 2017·1 cites·21 claims
- 0473US9340545B2Quinazolin-4 (3H)—one derivatives used as P13 kinase inhibitorsRESPIVERT LTD·Filed 2013·Granted May 17, 2016·1 cites·8 claims
- 0572US9771354B2Pyrazole p38 map kinase inhibitorsRESPIVERT LTD·Filed 2016·Granted Sep 26, 2017·1 cites·31 claims
- 0669US4504492APharmaceutical amides, and preparation, formulations and use thereofBURROUGHS WELLCOME CO·Filed 1982·Granted Mar 12, 1985·11 cites·13 claims
- 0768US4540682APharmaceutical peptides, preparation, use and intermediatesBURROUGHS WELLCOME CO·Filed 1984·Granted Sep 10, 1985·11 cites·42 claims
- 0864US4423242APharmaceutical amides, and preparation, formulations and use of thereofWELLCOME FOUND·Filed 1982·Granted Dec 27, 1983·7 cites·19 claims
- 0959US2018118754A1CompoundsRESPIVERT LTD·Filed 2017·Application pending·0 cites
- 1058US10028959B2Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitorsRESPIVERT LTD·Filed 2017·Granted Jul 24, 2018·0 cites·5 claims
- 1155US10000471B2Pyrazole P38 map kinase inhibitorsRESPIVERT LTD·Filed 2017·Granted Jun 19, 2018·0 cites·33 claims
- 1255US9637494B2Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitorsRESPIVERT LTD·Filed 2016·Granted May 2, 2017·0 cites·4 claims
- 1350US2013029990A1Pyrazole p38 map kinase inhibitorsKING-UNDERWOOD JOHN·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when George Hardy files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →